Belluscura Overview

  • Founded
  • 2015

Founded
  • Status
  • Public

  • Employees
  • 9

Employees
  • Stock Symbol
  • BELL

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $1.04

  • (As of Thursday Closing)

Belluscura General Information

Description

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25lbs) and it is the first modular portable oxygen concentrator and that it will generate more oxygen by weight than any other FDA cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Stock Exchange
LON
Primary Office
  • 15 Fetter Lane
  • London EC4A 1BW
  • England, United Kingdom

Belluscura Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Belluscura Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.04 $1.07 $0.75 - $2.08 $126M 121M 75.7K -$0.06

Belluscura Financials Summary

In Thousands,
USD
TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 149,420 149,420
Revenue 420 420 0 129
EBITDA (4,917) (4,917) (1,839) (1,407)
Net Income (5,213) (5,213) (1,978) (1,552)
Total Assets 26,005 26,005 5,237 4,530
Total Debt 370 370 495 498
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Belluscura Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Belluscura‘s full profile, request access.

Request a free trial

Belluscura Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Belluscura‘s full profile, request access.

Request a free trial

Belluscura Patents

Belluscura Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210196916-A1 Systems and methods for improving patient health Pending 11-Sep-2018 00000000000

Belluscura Executive Team (6)

Name Title Board Seat Contact Info
Robert Rauker JD Chief Executive Officer & Board Member
Anthony Dyer Chief Financial Officer & Board Member
Cary Parrott Vice President of Sales
You’re viewing 3 of 6 executive team members. Get the full list »

Belluscura Board Members (8)

Name Representing Role Since
Adam Reynolds Self Chairman 000 0000
Anthony Dyer Belluscura Chief Financial Officer & Board Member 000 0000
Patrick Strollo Self Board Member 000 0000
Robert Rauker JD Belluscura Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 8 board members. Get the full list »

Belluscura Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Belluscura Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Belluscura‘s full profile, request access.

Request a free trial

Belluscura Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 00 25-Apr-2017 0000000000 00000 Biotechnology 000000 00
Stryker Corporation (Medical Devices) 13-Apr-2016 Merger/Acquisition Other Commercial Services
To view Belluscura’s complete acquisitions history, request access »